Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,080 | 1,300 | 17.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.03. | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
12.03. | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
LAKESHORE BIOPHARMA Aktie jetzt für 0€ handeln | |||||
19.12.24 | LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance | 131 | PR Newswire | Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY
Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY
Gross margin... ► Artikel lesen | |
13.12.24 | LakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China | 159 | GlobeNewswire (Europe) | BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation... ► Artikel lesen | |
12.12.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
01.11.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | 11 | SEC Filings | ||
29.10.24 | LakeShore Biopharma erfüllt wieder Nasdaq-Anforderungen | 2 | Investing.com Deutsch | ||
25.10.24 | LakeShore Biopharma to test simplified rabies vaccine regimen | 2 | Investing.com | ||
25.10.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
25.10.24 | LakeShore Biopharma Co., Ltd.: LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine | 505 | PR Newswire | GAITHERSBURG, Md., Oct. 25, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical... ► Artikel lesen | |
10.10.24 | XFRA H6Z0: WIEDERAUFNAHME/RESUMPTION | 225 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
08.10.24 | LakeShore Biopharma Co., Ltd.: LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance | 176 | PR Newswire | GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering... ► Artikel lesen | |
04.10.24 | XFRA H6Z0: AUSSETZUNG/SUSPENSION | 342 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLAKESHORE BIOP.... ► Artikel lesen | |
04.10.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 04.10.2024 | 407 | Xetra Newsboard | The following instruments on XETRA do have their first trading 04.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.10.2024
Aktien
1 US59564R8079 Biodexa Pharmaceuticals... ► Artikel lesen | |
03.10.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 03.10.2024 | 546 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 03.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 03.10.2024ISIN NameUS59564R7089 BIODEXA... ► Artikel lesen | |
03.10.24 | XFRA ISIN CHANGE | 690 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA3874371147 Granite REIT LP 03.10.2024 CA3874372053 Granite REIT LP 04.10.2024 Tausch 1:1US86323X1063 Streamline... ► Artikel lesen | |
01.10.24 | XFRA H6Z: AUSSETZUNG/SUSPENSION | 285 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLAKESHORE BIOP.DL-... ► Artikel lesen | |
27.09.24 | LakeShore Biopharma Co., Ltd.: LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation | 250 | PR Newswire | GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering... ► Artikel lesen | |
15.08.24 | LakeShore Biopharma Co., Ltd: LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 | 641 | PR Newswire | Gross margin increased to 79.5%; product pipeline continues to advance
Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025
GAITHERSBURG,... ► Artikel lesen | |
24.05.24 | YS Biopharma Co., Ltd.: YS Biopharma Announces Name Change to LakeShore Biopharma | 274 | PR Newswire | GAITHERSBURG, Md., May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
---|